Evidence map›Paper›PMID 29332987›Full record

ArticleDisease markers2017

Elevated Serum miR-7, miR-9, miR-122, and miR-141 Are Noninvasive Biomarkers of Acute Pancreatitis.

Pan Lu, Feng Wang, Jia Wu, Cheng Wang, Jing Yan, Zhuo-Ling Li, Jia-Xi Song, Jun-Jun Wang

Open access · hybridAbstract read
In one paragraph

Article in Disease markers, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. The Role of MicroRNAs in Pancreatitis Development and Progression.International journal of molecular sciences · 2023
    Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Pan LuDepartment of Clinical Laboratory, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China.ORCID 0000-0002-9660-6685
Feng WangDepartment of Clinical Laboratory, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China.ORCID 0000-0003-1232-3707
Jia WuDepartment of Clinical Laboratory, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China.
Cheng WangDepartment of Clinical Laboratory, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China.
Jing YanDepartment of Clinical Laboratory, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China.ORCID 0000-0002-9617-5002
Zhuo-Ling LiDepartment of Clinical Laboratory, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China.ORCID 0000-0002-5868-5837
Jia-Xi SongDepartment of Clinical Laboratory, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China.ORCID 0000-0003-0292-1308
Jun-Jun WangDepartment of Clinical Laboratory, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China.ORCID 0000-0003-0507-1724
Nanjing General Hospital of Nanjing Military Command · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIt has been reported that several microRNAs (miRNAs), such as miR-141, miR-9, and miR-122, are involved in the regulation of pancreatitis-related proteins or that their levels change in acute pancreatitis (AP) animal models. However, the serum levels, as well as the clinical diagnostic and prognostic values, of these miRNAs in AP patients remain unclear. Furthermore, as a pancreas- (islet) enriched miRNA, miR-7 was reported to be downregulated in AP patients, which requires further verification.

methodsThe levels of miR-7, miR-9, miR-122, and miR-141 were examined and compared using qRT-PCR among 80 severe AP patients, 80 mild AP patients, and 74 healthy controls.

resultsThe serum levels of these four miRNAs were increased markedly in the AP patients compared with the controls, and these levels decreased significantly after effective therapy. Particularly, the level of miR-7 was higher in severe AP patients than in mild AP patients. ROC curve analysis demonstrated that four miRNAs could be used as potential biomarkers for AP. Moreover, these miRNAs showed strong positive correlations with CRP, which may be associated with inflammation.

conclusionsThe serum miR-7, miR-9, miR-122, and miR-141 levels were increased in AP patients. These 4 miRNAs may represent diagnostic and prognostic biomarkers for AP.

Indexed as

AdultBiomarkersFemaleHumansMaleMicroRNAsMiddle AgedPancreatitis, Acute NecrotizingBiomarkersMicroRNAs

Identifiers

PMID29332987
PMCPMC5733206
OpenAlexW2772886801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.